+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma



MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma



Journal of International Medical Research 46(3): 975-983



Objective This study was performed to examine serum microRNA-375 (miR-375) expression in patients with osteosarcoma and determine its diagnostic and prognostic value. Methods Serum samples were obtained from 95 patients with osteosarcoma and 95 healthy individuals. miR-375 expression was detected by real-time polymerase chain reaction. The associations of serum miR-375 expression with the patients' clinicopathological characteristics and prognosis were then evaluated. Receiver operating characteristic curve analysis was performed to obtain the potential value of serum miR-375 as a biomarker for osteosarcoma diagnosis and chemosensitivity prediction. Results Serum miR-375 expression was significantly lower in patients with osteosarcoma than in healthy individuals. Low serum miR-375 levels were associated with advanced clinical stages, large tumor size, positive distant metastasis, and poor tumor response to preoperative chemotherapy. Receiver operating characteristic curve analysis illustrated that serum miR-375 could distinguish patients with osteosarcoma from healthy individuals and distinguish patients with a good pathologic response from those with a poor response. Multivariate analysis confirmed low serum miR-375 expression as a statistically significant independent unfavorable prognostic factor. Conclusions Serum miR-375 expression was downregulated in patients with osteosarcoma and might serve as a biomarker for its diagnosis, prognosis, and chemosensitivity prediction.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059969018

Download citation: RISBibTeXText

PMID: 29115164

DOI: 10.1177/0300060517734114


Related references

Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma. Journal of International Medical Research 40(6): 2090-2097, 2012

Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma. Cancer Biomarkers 15(5): 543-550, 2016

miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma. European Review for Medical and Pharmacological Sciences 20(18): 3765-3769, 2017

Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma. Cancer Biomarkers 21(2): 449-454, 2017

A novel circulating hsa_circ_0081001 act as a potential biomarker for diagnosis and prognosis of osteosarcoma. International Journal of Biological Sciences 14(11): 1513-1520, 2018

MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer. Cancer Biology and Medicine 12(4): 328-341, 2016

Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clinical Chemistry 58(3): 610-618, 2012

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Science 101(10): 2087-2092, 2010

Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis. Biomarkers in Medicine 11(5): 431-441, 2018

MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma. European Review for Medical and Pharmacological Sciences 20(7): 1258-1262, 2016

Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis. Molecular Neurobiology 53(1): 163-170, 2016

MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer. Cancer Cell International 16: 12, 2016

Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. International Journal of Clinical and Experimental Pathology 7(7): 4194-4203, 2015

microRNA-138-5p as a Worse Prognosis Biomarker in Pediatric, Adolescent, and Young Adult Osteosarcoma. Pathology Oncology Research 2019, 2019

Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma. Tumour Biology 37(5): 5769-5773, 2015